Orthofix Medical Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 746.64 million compared to USD 460.71 million a year ago. Net loss was USD 151.4 million compared to USD 19.75 million a year ago.

Basic loss per share from continuing operations was USD 4.12 compared to USD 0.98 a year ago. Diluted loss per share from continuing operations was USD 4.12 compared to USD 0.98 a year ago.